Overall Survival Benefit with Sacituzumab Govitecan in Metastatic Breast Cancer: A Post Hoc Interaction Analyses of a Randomized Controlled Trail.

Clin Drug Investig

School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, #24 Tongjia Lane, Nanjing, 210009, Jiangsu, China.

Published: June 2024

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40261-024-01367-xDOI Listing

Publication Analysis

Top Keywords

survival benefit
4
benefit sacituzumab
4
sacituzumab govitecan
4
govitecan metastatic
4
metastatic breast
4
breast cancer
4
cancer post
4
post hoc
4
hoc interaction
4
interaction analyses
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!